Smithers, a bioanalytical contract research organization (CRO), supports the development of large molecule therapeutics from discovery through phase IV, with expertise in bioassays and ultra-sensitive ligand-binding assays. Our services focus on development, validation and sample analysis for PK/TK, ADA, bioassays and fit-for purpose biomarker studies. Smithers supports biologics/monoclonal & polyclonal antibodies/bi-specific antibodies/CAR-T/TCR/gene therapy/biosimilars and biobetters, among many other therapeutic technologies.


Email: [email protected]